Drugs / HEC113995
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04623814 | Mar → Aug 2020 | major depressive disorder | Sunshine Lake Pharma Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HEC113995 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04623814 ↗ |
| Route | Oral | “HEC113995 will be taken orally fasted (HEC113995 10mg）or with food (HEC113995 20mg and 40mg） for 10 days” NCT04623814 ↗ |